Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prostate Cancer
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Leukemia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Trial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Clinical Trial Market Perspective (2017-2028)
2.2 Oncology Clinical Trial Growth Trends by Region
2.2.1 Oncology Clinical Trial Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Clinical Trial Historic Market Size by Region (2017-2022)
2.2.3 Oncology Clinical Trial Forecasted Market Size by Region (2023-2028)
2.3 Oncology Clinical Trial Market Dynamics
2.3.1 Oncology Clinical Trial Industry Trends
2.3.2 Oncology Clinical Trial Market Drivers
2.3.3 Oncology Clinical Trial Market Challenges
2.3.4 Oncology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Trial Players by Revenue
3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2017-2022)
3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
3.4 Global Oncology Clinical Trial Market Concentration Ratio
3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2021
3.5 Oncology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Oncology Clinical Trial Product Solution and Service
3.7 Date of Enter into Oncology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Clinical Trial Breakdown Data by Type
4.1 Global Oncology Clinical Trial Historic Market Size by Type (2017-2022)
4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2023-2028)
5 Oncology Clinical Trial Breakdown Data by Application
5.1 Global Oncology Clinical Trial Historic Market Size by Application (2017-2022)
5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Clinical Trial Market Size (2017-2028)
6.2 North America Oncology Clinical Trial Market Size by Type
6.2.1 North America Oncology Clinical Trial Market Size by Type (2017-2022)
6.2.2 North America Oncology Clinical Trial Market Size by Type (2023-2028)
6.2.3 North America Oncology Clinical Trial Market Share by Type (2017-2028)
6.3 North America Oncology Clinical Trial Market Size by Application
6.3.1 North America Oncology Clinical Trial Market Size by Application (2017-2022)
6.3.2 North America Oncology Clinical Trial Market Size by Application (2023-2028)
6.3.3 North America Oncology Clinical Trial Market Share by Application (2017-2028)
6.4 North America Oncology Clinical Trial Market Size by Country
6.4.1 North America Oncology Clinical Trial Market Size by Country (2017-2022)
6.4.2 North America Oncology Clinical Trial Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Clinical Trial Market Size (2017-2028)
7.2 Europe Oncology Clinical Trial Market Size by Type
7.2.1 Europe Oncology Clinical Trial Market Size by Type (2017-2022)
7.2.2 Europe Oncology Clinical Trial Market Size by Type (2023-2028)
7.2.3 Europe Oncology Clinical Trial Market Share by Type (2017-2028)
7.3 Europe Oncology Clinical Trial Market Size by Application
7.3.1 Europe Oncology Clinical Trial Market Size by Application (2017-2022)
7.3.2 Europe Oncology Clinical Trial Market Size by Application (2023-2028)
7.3.3 Europe Oncology Clinical Trial Market Share by Application (2017-2028)
7.4 Europe Oncology Clinical Trial Market Size by Country
7.4.1 Europe Oncology Clinical Trial Market Size by Country (2017-2022)
7.4.2 Europe Oncology Clinical Trial Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Trial Market Size (2017-2028)
8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Clinical Trial Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Clinical Trial Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Clinical Trial Market Size (2017-2028)
9.2 Latin America Oncology Clinical Trial Market Size by Type
9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Clinical Trial Market Share by Type (2017-2028)
9.3 Latin America Oncology Clinical Trial Market Size by Application
9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Clinical Trial Market Share by Application (2017-2028)
9.4 Latin America Oncology Clinical Trial Market Size by Country
9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Trial Market Size (2017-2028)
10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Clinical Trial Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Clinical Trial Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Oncology Clinical Trial Introduction
11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2017-2022)
11.1.5 IQVIA Recent Developments
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2017-2022)
11.2.5 Charles River Laboratory Recent Developments
11.3 ICON Plc
11.3.1 ICON Plc Company Details
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Oncology Clinical Trial Introduction
11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2017-2022)
11.3.5 ICON Plc Recent Developments
11.4 Medelis, Inc.
11.4.1 Medelis, Inc. Company Details
11.4.2 Medelis, Inc. Business Overview
11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2017-2022)
11.4.5 Medelis, Inc. Recent Developments
11.5 Medpace Holdings, Inc.
11.5.1 Medpace Holdings, Inc. Company Details
11.5.2 Medpace Holdings, Inc. Business Overview
11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2017-2022)
11.5.5 Medpace Holdings, Inc. Recent Developments
11.6 PAREXEL International
11.6.1 PAREXEL International Company Details
11.6.2 PAREXEL International Business Overview
11.6.3 PAREXEL International Oncology Clinical Trial Introduction
11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2017-2022)
11.6.5 PAREXEL International Recent Developments
11.7 Pharmaceutical Product Development, LLC
11.7.1 Pharmaceutical Product Development, LLC Company Details
11.7.2 Pharmaceutical Product Development, LLC Business Overview
11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2017-2022)
11.7.5 Pharmaceutical Product Development, LLC Recent Developments
11.8 Pivotal
11.8.1 Pivotal Company Details
11.8.2 Pivotal Business Overview
11.8.3 Pivotal Oncology Clinical Trial Introduction
11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2017-2022)
11.8.5 Pivotal Recent Developments
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2017-2022)
11.9.5 PRA Health Sciences Recent Developments
11.10 Syneos Health
11.10.1 Syneos Health Company Details
11.10.2 Syneos Health Business Overview
11.10.3 Syneos Health Oncology Clinical Trial Introduction
11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2017-2022)
11.10.5 Syneos Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer